다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Enliven Therapeutics Inc (ELVN)
Enliven Therapeutics Inc (ELVN) 뉴스

ELVN

Enliven Therapeutics (ELVN)

Enliven Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ELVN

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/19	06:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/06/11	07:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/06/01	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/31	06:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/31	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/30	05:08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/30	05:06	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/30	05:05	GlobeNewswire Inc.	Enliven Therapeutics to Present at Two Upcoming Investor Conferences	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/29	06:45	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/29	06:29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/17	08:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/15	05:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/15	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/15	05:05	GlobeNewswire Inc.	Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/14	08:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/09	09:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/05/08	07:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/04/11	20:55	GlobeNewswire Inc.	Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/04/10	05:05	GlobeNewswire Inc.	Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/03/29	05:05	GlobeNewswire Inc.	Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/03/19	21:30	GlobeNewswire Inc.	Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/03/15	05:05	GlobeNewswire Inc.	Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/03/09	09:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/03/07	07:43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/03/05	07:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/03/01	07:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/02/28	06:05	GlobeNewswire Inc.	Enliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/02/28	06:02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/02/21	09:35	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ELVN	Enliven Therapeutics Inc
2024/02/21	09:27	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ELVN	Enliven Therapeutics Inc

검색 관련기사 보기:NASDAQ:ELVN

1 2 3 4 다음 >>

Spotify Technology

Vontobel Financial Produ...

BNP Paribas Issuance

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관